Cencora, Inc.

US$333.56As of Sun 8 Nov 2026, 12:00 UTC

NYSE:CORHealthcare

Country USA

PE (Fwd) •••

TSR 10Y CAGR 20.22%

Div yield 0.79%

ROE 129.01%

Medical Distribution

Beta (5Y) 0.57

PE TTM 18.58

TSR TTM (0.51%)

Mkt cap US$63.65B

ROIC 28.62%

SE Grade™

Value

Quality

Moat

Consensus

Reference

$394

18.06%

(98.12%)

Hold 0|3|4|1|3

TTM

FYE 30 Sep USD

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

0.970

Revenue$B

19.91

19.59

19.70

19.86

20.09

19.77

20.14

20.35

19.96

20.27

1.031

0.18%

0.12%

15.61

Revenue growth%

17.48

16.77

16.69

18.43

19.45

18.50

19.11

21.42

19.49

16.94

21.65

19.11

18.46

27.18

Gross margin%

14.47

13.40

15.16

14.42

13.81

12.30

12.58

15.25

17.86

19.05

15.20

15.25

14.44

5.99

Operating margin%

4.75

4.36

1.80

0.40

1.61

2.76

3.24

2.63

4.61

3.27

6.48

3.24

3.00

19.90

Net margin%

24.51

25.72

24.41

23.86

26.71

24.79

24.31

24.21

25.86

25.14

12.90

24.79

24.65

37.39

P/E ratio (avg)x

17.83

18.51

16.25

14.51

12.83

12.71

11.29

10.81

11.12

12.00

34.79

11.29

12.77

19.33

EV/EBITx

27.98

27.71

30.08

30.50

31.32

29.25

26.66

27.36

24.71

22.57

32.25

26.66

27.84

28.11

FCF yield (avg)%

7.21

7.79

9.66

7.24

8.89

7.17

9.78

9.92

10.53

10.94

8.58

9.92

9.28

13.23

FCF margin%

22.39

20.89

20.28

18.76

19.89

19.21

17.84

17.74

19.61

17.06

13.86

17.84

19.41

1.064

FCF / Net incomex

0.240

0.238

0.233

0.238

0.262

0.257

0.265

0.309

0.313

0.317

1.336

0.309

0.259

20.93

ROIC%

12.10

12.45

14.54

14.21

11.80

12.19

9.86

10.84

11.74

10.92

8.50

10.92

11.95

11.72

Return on equity%

28.85

27.53

24.72

23.39

22.30

22.80

23.28

24.95

24.67

24.19

14.65

24.19

24.43

13.85

Return on assets%

22.87

23.79

23.21

24.12

26.42

24.08

24.88

23.67

21.03

20.62

13.53

23.67

23.73

8.48

EPS$

39.37

37.49

38.54

35.40

31.59

28.48

29.24

29.23

32.73

32.44

9.34

0.53%

(0.89%)

—

3.55

EPS growth%

23.59

26.32

24.46

25.20

28.16

26.03

24.34

26.25

25.69

28.65

23.95

26.03

25.86

37.43

Bookvalue per sh$

25.71

29.25

29.28

29.38

33.90

39.41

37.97

41.02

41.08

43.61

12.32

5.17%

5.87%

—

17.86

FCF per share$

20.67

20.16

18.59

19.14

18.25

16.31

15.73

16.32

16.85

17.43

33.83

(0.92%)

(1.87%)

—

9.21

Dividend per sh$

36.79

36.76

40.50

40.23

35.89

34.58

33.25

34.66

35.49

34.46

36.84

(0.81%)

(0.13%)

—

28.14

Div yield (avg)%

11.03

8.23

11.12

9.22

11.61

14.45

14.40

12.04

9.11

11.13

22.28

12.04

11.13

9.48

Payout ratio%

4.00

3.88

3.31

4.19

1.72

1.77

1.35

2.79

0.46

3.01

15.77

1.77

2.90

195.3

Shares (diluted)M

155.4

156.5

168.6

143.9

136.5

139.4

147.3

151.6

136.6

187.2

(1.03%)

(2.22%)

7.00

Buyback yield%

19.55

22.16

19.90

18.74

18.79

20.17

17.71

17.01

16.54

16.29

12.22

17.01

18.77

1.116

D/E ratiox

0.939

1.026

1.084

1.103

1.078

1.033

1.067

1.093

1.175

1.180

0.808

1.093

1.081

16.48

Enterprise value$B

8.452

8.796

8.784

7.671

8.268

8.632

9.026

7.995

7.420

8.024

8.388

(0.60%)

(1.13%)

19.89

LT debt$B

6.752

6.524

5.867

5.808

5.269

5.259

5.107

5.595

5.037

4.908

11.69

(1.41%)

(3.51%)

Peers (US$63.65B)

Cap (US$)

McKesson Corporation

122.5B

27.22x

Cardinal Health, Inc.

62.80B

35.18x

Henry Schein, Inc.

9.512B

23.58x

The Cigna Group

77.36B

12.96x

Capital

TTM

10Y

Leveragex

2.656

(0.397)

(0.308)

EBIT/Intx

1.340

0.120

0.145

Own earn%

(347.10)

(33.47)

(24.62)

Sh yield%

35.14

29.06

30.39

Owners

Insiders/Inst%

5.27

59.27

Short interest%

5.28

SBC / revenue%

3.35

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

Op margin range%

0–5

$1 testx

—

Incr. ROIC%

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally, supplying generic and specialty drugs, vaccines, blood products and healthcare supplies to hospitals, pharmacies, clinics and physicians, along with consulting, software, packaging, commercialization and data services for manufacturers, animal health products, and international wholesale and specialty logistics services.

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

$20.27B

0.12%

1.00×

Cost of revenue

$12.82B

0.20%

1.01×

Operating expenses

$4.052B

0.27%

1.01×